4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ALX Oncology Holdings Inc. (ALXO) operates in the Biotechnology industry and is headquartered in South San Francisco, United States with about 43 employees. Its market capitalization is roughly $273 million. In the fiscal year ended 2025-12-31, ALXO reported $0M in revenue and ($102M) in net income.
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | $0M | $0M |
| Operating Income (EBIT) | ($101M) | ($142M) | ($170M) | ($127M) | — |
| Net Income | ($102M) | ($135M) | ($161M) | ($124M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($19M) | ($23M) | ($22M) | ($24M) | ($32M) |
| Net Income | ($18M) | ($23M) | ($22M) | ($26M) | ($31M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $59M | $148M | $243M | $306M | — |
| Total Liabilities | $33M | $34M | $53M | $43M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALXO viewer.
About TickerBase · Data methodology & sources